Desai Veeral's Form 4 filing
agilon health, inc. (AGL) · filed Mar 17, 2023
- Accession no.
- 0001209191-23-019722
- Filed
- Mar 17, 2023
- Trade date
- Mar 16, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.57M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Desai VeeralCIK 0001855973 | Officer (Chief Strategy & Dev. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Common Stock | MOption exerciseAcquired | +60,000 | $3.00 | +$180,000 | 336,729 | Direct | |
| Mar 16, 2023 | Common Stock | SSaleDisposed | −60,000 | $26.09 | −$1,565,400 | 276,729 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Common Stock | MOption exerciseDisposed | −60,000 | $0.00 | $0 | 1,640,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.